Q.Developing a vaccine for SARS is difficult because:
You're viewing a preview — the full solution, concept, methods & PYQ mapping are locked.
Start your 14-day free trial to unlock the full solution →Vaccine development against SARS is difficult mainly because the virus's RNA genome mutates rapidly, continuously changing its surface antigens (antigenic variation), so immunity built against one strain may not protect against the next.
Vaccines work by training the immune system to recognize specific viral surface proteins (antigens). RNA viruses like the SARS coronavirus replicate using an RNA-dependent RNA polymerase that lacks efficient proofreading, so errors (mutations) accumulate much faster than in DNA-based organisms. This continuous change in the virus's surface antigens (antigenic drift) means antibodies raised against an earlier form of the virus may fail to recognize a later, mutated form - making a single, durable vaccine much harder to design.
…
Unlock everything free for 14 days
- Full step-by-step solutions
- Concept-first explanations
- Methods, shortcuts & mistakes
- PYQ mapping + timed mock tests
Full access for 14 days. No credit card required.